Fulgent Genetics
- Market cap
- 565.99M
- P/E (TTM)i
- -7.27
- P/Bi
- 0.57
- EPSi
- -1.97
- Div yieldi
- 0.00%
- 52W posi
- 40%
Anonymous reader poll. Unscientific, not investment advice.
Fulgent Genetics last traded at 20.57, little changed on the session. That leaves the company valued at approximately 565.99M, the #3667 most valuable US-listed company we track. Across 1 analysts the consensus rating is Hold, with an average price target of 19.00 (-8%). The shares sit 40% of the way up their 52-week range of 13.46 to 31.04.
✦ StockVane Quant Insights how this is computed
- Not yet in the StockVane Momentum strategy's universe - this name needs price history back to 2021 for a reliable signal and doesn't have it yet (most often because it IPO'd or was spun off more recently). This grade is a preliminary blend of valuation, momentum and analyst data, not a Momentum buy/sell call.
- Price momentum averages -5.6% across the trailing 3-month/1-year windows.
- Analyst consensus across 1 analysts is Hold.
- Recent price momentum is -5.6% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 8.4% of float.
- Analyst tilt is Hold.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 20.58
- Open
- 20.48
- Day range
- 19.90 - 20.70
- Avg price
- 20.42
- Volume
- 298.27K
- Turnover
- 6.09M
- Turnover ratei
- 1.79%
- Volume ratioi
- 0.93
- Amplitudei
- 3.89%
- 52-week rangei
- 13.46 - 31.04
Valuation
- P/Ei
- -10.44
- P/E (TTM)i
- -7.27
- P/Bi
- 0.57
- EPSi
- -1.97
- Book value / shi
- 36.40
- Net profit
- -54.21M
- Net assets
- 1.00B
Share structure
- Market cap
- 565.99M
- Float capi
- 343.34M
- Shares out
- 27.52M
- Float sharesi
- 16.69M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2016-09-29
33.7% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-1.32M net over the window
Short interest
- Shares short
- 2.32M
- % of floati
- 8.42%
- Days to coveri
- 6.71
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Fulgent Genetics (FLGT)?
Fulgent Genetics last traded at 20.57. The quote on this page refreshes every few seconds while US markets are open.
What is Fulgent Genetics's market cap?
About 565.99M.
What is the P/E ratio of Fulgent Genetics?
The trailing twelve-month P/E is -7.27. The Valuation tab shows it against the stock's own five-year range.
Does Fulgent Genetics pay a dividend?
Fulgent Genetics does not currently pay a regular dividend.
Is Fulgent Genetics a buy according to analysts?
The consensus of 1 analysts is a Hold rating, with an average 12-month price target of 19.00, which implies 7.6% downside from the current price. This is not investment advice.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.